⌘K

Login Start Free

Home/Filings/4/0001247741-03-000003

4//SEC Filing

LIGAND PHARMACEUTICALS INC 4

Accession 0001247741-03-000003

$LGNDCIK 0000886163operating

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:03 PM ET

Size

18.2 KB

Accession

0001247741-03-000003

Insider Transaction Report

Form 4

Period: 2003-11-20

LIGAND PHARMACEUTICALS INCLGND

JOHNSON IRVING S

Director

Transactions

Exercise/Conversion
Common Stock
2003-11-20$5.81/sh+8,118$47,186→ 31,047 total
Sale
Common Stock
2003-11-20$12.00/sh−8,118$97,416→ 22,929 total
Exercise/Conversion
Common Stock
2003-11-20$4.58/sh+1,527$6,998→ 24,456 total
Exercise/Conversion
Common Stock
2003-11-20$5.68/sh+1,583$8,996→ 24,512 total
Sale
Common Stock
2003-11-20$12.00/sh−1,583$18,996→ 22,929 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-11-20$12.00/sh−1,527$18,324→ 0 total
Exercise: $4.58Exp: 2011-01-02→ Common Stock (1,527 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-11-20$12.00/sh−1,583$18,996→ 0 total
Exercise: $5.68Exp: 2012-01-02→ Common Stock (1,583 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-11-20$12.00/sh−8,118$97,416→ 0 total
Exercise: $5.81From: 1996-05-17Exp: 2005-05-17→ Common Stock (8,118 underlying)
Sale
Common Stock
2003-11-20$12.00/sh−1,527$18,324→ 22,929 total

Footnotes (2)

[F1]The option becomes exercisable in twelve successive equal monthly installments upon completion of each calendar month of service beginning 1/31/01.
[F2]The option becomes exercisable in twelve successive equal monthly installments upon completion of each calendar month of service beginning 1/31/02.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000886163

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 4:03 PM ET
Size: 18.2 KB

View on SEC.gov